Taysha Gene Therapies, Inc. (TSHA)
4.39
0.00 (0.00%)
USD |
NASDAQ |
Oct 07, 12:19
Taysha Gene Therapies Market Cap : 1.428B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.428B |
| October 05, 2026 | 1.461B |
| October 02, 2026 | 1.506B |
| October 01, 2026 | 1.542B |
| September 30, 2026 | 1.584B |
| September 29, 2026 | 1.623B |
| September 28, 2026 | 1.623B |
| September 25, 2026 | 1.519B |
| September 24, 2026 | 1.558B |
| September 23, 2026 | 1.597B |
| September 22, 2026 | 1.679B |
| September 21, 2026 | 1.640B |
| September 18, 2026 | 1.633B |
| September 17, 2026 | 1.679B |
| September 16, 2026 | 1.649B |
| September 15, 2026 | 1.646B |
| September 14, 2026 | 1.630B |
| September 11, 2026 | 1.633B |
| September 10, 2026 | 1.679B |
| September 09, 2026 | 1.737B |
| September 08, 2026 | 1.783B |
| September 04, 2026 | 1.822B |
| September 03, 2026 | 1.812B |
| September 02, 2026 | 1.835B |
| September 01, 2026 | 1.854B |
| Date | Value |
|---|---|
| August 31, 2026 | 1.851B |
| August 28, 2026 | 1.877B |
| August 27, 2026 | 1.939B |
| August 26, 2026 | 1.958B |
| August 25, 2026 | 2.017B |
| August 24, 2026 | 1.942B |
| August 21, 2026 | 1.981B |
| August 20, 2026 | 1.988B |
| August 19, 2026 | 2.092B |
| August 18, 2026 | 2.014B |
| August 17, 2026 | 2.020B |
| August 14, 2026 | 1.936B |
| August 13, 2026 | 1.949B |
| August 12, 2026 | 2.084B |
| August 11, 2026 | 2.173B |
| August 10, 2026 | 2.072B |
| August 07, 2026 | 2.134B |
| August 06, 2026 | 1.821B |
| August 05, 2026 | 1.856B |
| August 04, 2026 | 1.781B |
| August 03, 2026 | 1.660B |
| July 31, 2026 | 1.683B |
| July 30, 2026 | 1.688B |
| July 29, 2026 | 1.612B |
| July 28, 2026 | 1.569B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 528.00M |
| Protalix Biotherapeutics, Inc. | 221.97M |
| Humacyte, Inc. | 129.18M |
| Agenus, Inc. | 321.32M |
| Amgen, Inc. | 224.03B |
Market Cap Related Metrics
| PS Ratio | 274.93 |
| PEG Ratio | -0.4815 |
| Price to Book Value | 3.688 |
| Price | 4.39 |
| Earnings Yield | -9.85% |
| PEGY Ratio | -0.4815 |